MRSN Stock Analysis: Buy, Sell, or Hold?
MRSN - Mersana Therapeutics, Inc. Common Stock
$29.08
0.04 (0.14%)
▲
5d:
+0.02%
30d:
+5.1%
90d:
+251.21%
BUY
MODERATE Confidence
Last Updated: January 5, 2026
Get Alerted When MRSN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MRSN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MRSN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MRSN is currently trading at $29.08, which is considered slightly high relative to its 30-day fair value range of $28.75 to $29.09.
Technical Outlook: Technically, MRSN is in a strong uptrend. Immediate support is located at $28.11, while resistance sits at $30.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.20 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MRSN is in a strong uptrend. Immediate support is located at $28.11, while resistance sits at $30.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.20 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$28.75 -
$29.09
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($33.20)
Fair Price Analysis
30-Day Fair Range
$28.75 -
$29.09
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$28.11
Resistance Level
$30.39
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$33.20
(+14.2%)
Revenue Growth (YoY)
-12.6%
Profit Margin
-211.2%
Last updated: February 02, 2026 8:54 AM ET
Data refreshes hourly during market hours. Next update: 9:54 AM
Data refreshes hourly during market hours. Next update: 9:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRSN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Martin H Jr. Huber
SELL
2012 shares
2025-09-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |
